Change in Ratings

Research in Motion

( RIMM) added to Goldman's conviction buy list based on valuation, a stronger dollar and attractive pipeline. Sees 44% upside to its 12-month target of $68, based on 19x P/E.

J.M. Smucker

(SJM) - Get Report

upgraded at Merrill from Underperform to Buy. $48 price target. Estimates also raised to reflect stronger expected volume and lower commodity costs.


(SUN) - Get Report

downgraded at Deutsche Bank from Hold to Sell. Valuation call, based on lower expected demand and oil prices.

United Therapeutics

(UTHR) - Get Report

upgraded at Piper Jaffray to Neutral from Sell. Says near-term risk is limited following sell-off. Lowered target price to $60 from $71.

Stock Comments/EPS Changes


(MDT) - Get Report

target cut at Credit Suisse to $37 from $49 based on low visibility following Q2 results. Maintained Neutral rating.

St. Jude Medical


target lowered at Credit Suisse to $31 from $38. Says 2009 is likely to be very challenging and foreign exchange is a big headwind. Maintained Neutral rating.

This article was written by a staff member of